Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $163,219 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $163,219 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $163,219 | 3 | PFIZER INC. ($163,219) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2020 | Pfizer Inc. | — | Grant | Cash or cash equivalent | $41,609.37 | General |
| 12/31/2020 | Pfizer Inc. | — | Grant | Cash or cash equivalent | $41,609.37 | General |
| 06/30/2020 | PFIZER INC. | — | Grant | Cash or cash equivalent | $80,000.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 179 | 198 | $56,141 | $16,828 |
| 2022 | 8 | 213 | 253 | $79,981 | $16,578 |
| 2021 | 8 | 166 | 187 | $54,539 | $12,275 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 49 | $12,495 | $4,529 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $9,360 | $2,964 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $8,160 | $2,546 | 31.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 31 | 32 | $12,160 | $2,336 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 22 | $3,784 | $1,430 | 37.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 14 | 15 | $3,915 | $1,291 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $3,784 | $1,272 | 33.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 12 | 13 | $2,483 | $459.24 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 47 | $19,640 | $4,183 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $13,032 | $2,601 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 38 | $11,239 | $2,418 | 21.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $10,205 | $2,147 | 21.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 24 | 26 | $10,188 | $2,142 | 21.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 23 | 27 | $9,669 | $2,072 | 21.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 21 | 22 | $5,078 | $826.42 | 16.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 14 | 41 | $930.00 | $188.88 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 28 | $11,020 | $2,639 | 23.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 22 | 22 | $8,644 | $1,914 | 22.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 28 | $7,696 | $1,888 | 24.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $7,061 | $1,758 | 24.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 23 | 23 | $8,176 | $1,613 | 19.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $6,857 | $1,557 | 22.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 19 | 19 | $4,331 | $732.07 | 16.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 15 | 35 | $754.00 | $173.92 | 23.1% |
About Dr. Emily Cole, MD
Dr. Emily Cole, MD is a Internal Medicine healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2015. The National Provider Identifier (NPI) number assigned to this provider is 1194105981.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emily Cole, MD has received a total of $163,219 in payments from pharmaceutical and medical device companies, with $163,219 received in 2020. These payments were reported across 3 transactions from 1 company. The most common payment nature is "Grant" ($163,219).
As a Medicare-enrolled provider, Cole has provided services to 558 Medicare beneficiaries, totaling 638 services with total Medicare billing of $45,681. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Dermatology
- Location Saint Louis, MO
- Active Since 06/05/2015
- Last Updated 08/21/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1194105981
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Saint Louis
Dr. John Lasala, Md, MD
Internal Medicine — Payments: $1.1M
Dr. Mark Fesler, Md, MD
Internal Medicine — Payments: $700,896
Dr. Katie Schroeder, Md, MD
Internal Medicine — Payments: $659,683
Edward Charbek, Md, MD
Internal Medicine — Payments: $260,967
Dr. Michael Reschak, M.d, M.D
Internal Medicine — Payments: $245,910
Dr. Osler Jay Guzon, Md, MD
Internal Medicine — Payments: $237,841